(Q36250583)

13 August 2017

In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia (English)

1 reference

methicillin-resistant Staphylococcus aureus

13 August 2017

0 references

sepsis

0 references

(1R,2S)-epoxypropylphosphonate(2-)

1 reference

ChEBI release 2020-05-28

ChEBI ID

62419

Staphylococcus aureus

1 reference

Lau WY

1

1 reference

13 August 2017

Teoh-Chan CH

series ordinal

2

1 reference

13 August 2017

Fan ST

series ordinal

3

1 reference

13 August 2017

Lau KF

series ordinal

4

1 reference

13 August 2017

1 June 1986

1 reference

13 August 2017

The Journal of Hygiene

1 reference

13 August 2017

96

1 reference

13 August 2017

419-423

1 reference

13 August 2017

3

1 reference

Interaction Between Vancomycin and Rifampin Against Staphylococcus aureus

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

Bacteremia due to methicillin-resistant Staphylococcus aureus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

Activity of fosfomycin in the treatment of bacterial infections

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2129703

Clinical pharmacology and in vitro activity of phosphonomycin

29 June 2018

1 reference

12 December 2020

Treatment of infections due to methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

The emergence of methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

International recognition of methicillin-resistant strains of Staphylococcus aureus

1 reference

12 December 2020

International collaborative study on standardization of bacterial sensitivity to fosfomycin

1 reference

12 December 2020

Recent developments in the field of phosphonic acid antibiotics

1 reference

12 December 2020

Reevaluation of fosfomycin: clinical and laboratory studies

1 reference

12 December 2020

Fosfomycin in chronic urinary infections

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus

1 reference

Crossref

https://api.crossref.org/works/10.1017%2FS0022172400066183

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1017/S0022172400066183

1 reference

13 August 2017

1 reference

13 August 2017

1 reference